Abstract
Nonpharmacological treatment methods are widely accepted as preventive or therapeutic measures in prehypertension or hypertension and heart failure. Diet intervention such as DASH or the Mediterranean diet can be recommended for these patients. Interventions aimed at weight reduction in overweight patients and avoidance of excessive use of sodium in diet can help to decrease symptoms and lower excessive blood pressure, especially when added to pharmacological therapy. A substitution of alcohol consumption for nonalcoholic beverages without sugar should be advised. All patients with hypertension and stable heart failure should be encouraged to exercise at least moderate physical aerobic activity to improve exercise capacity, quality of life, and reduce HF hospitalizations. Patients with advanced heart failure can also profit safely from moderate aerobic exercise programs like “Nordic walking” activities. The benefit of relaxation techniques is demonstrated. Electronic devices like smartphone applications can help in dietary, physical exercise, and self-control programs. Many of the methods presented are complementary, and the best effects can be obtained when used together, such as weight reduction programs with exercise activity and other components of a healthy lifestyle.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336(16):1117–24.
Campos CL, Wood A, Burke GL, Bahrami H, Bertoni AG. Dietary approaches to stop hypertension diet concordance and incident heart failure: the multi-ethnic study of atherosclerosis. Am J Prev Med. 2019;56(6):819–26.
Goyal P, Balkan L, Ringel JB, Hummel SL, Sterling MR, Kim S, et al. The dietary approaches to stop hypertension (DASH) diet pattern and incident heart failure. J Card Fail. 2021;27(5):512–21.
Ibsen DB, Levitan EB, Akesson A, Gigante B, Wolk A. The dietary approach to stop hypertension (DASH) diet is associated with a lower risk of heart failure: a cohort study. Eur J Prev Cardiol. 2022;29:1114.
Sanches Machado d’Almeida K, Ronchi Spillere S, Zuchinali P, Correa SG. Mediterranean diet and other dietary patterns in primary prevention of heart failure and changes in cardiac function markers: a systematic review. Nutrients. 2018;10(1):58.
Verma N, Rastogi S, Chia YC, Siddique S, Turana Y, Cheng HM, et al. Non-pharmacological management of hypertension. J Clin Hypertens. 2021;23(7):1275–83.
Patel YR, Robbins JM, Gaziano JM, Djousse L. Mediterranean, DASH, and alternate healthy eating index dietary patterns and risk of death in the Physicians’ health study. Nutrients. 2021;13(6):1893.
Chang C-Y, Lee C-L, Liu W-J, Wang J-S. Association of adherence to the mediterranean diet with all-cause mortality in subjects with heart failure. Nutrients. 2022;14(4):842.
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.
Tschanz CMP, Cushman WC, Harrell CTE, Berlowitz DR, Sall JL. Synopsis of the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense clinical practice guideline: the diagnosis and management of hypertension in the primary care setting. Ann Intern Med. 2020;173(11):904–13.
Ezekowitz JA, Colin-Ramirez E, Ross H, Escobedo J, Macdonald P, Troughton R, et al. Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial. Lancet. 2022;399(10333):1391–400.
Damy T, Benedyga V, Pezel T, Berthelot E, Gauthier J, Habib G, et al. Prescription, compliance, and burden associated with salt-restricted diets in heart failure patients: results from the French national OFICSel observatory. Nutrients. 2022;14(2):308.
Iqbal S, Klammer N, Ekmekcioglu C. The effect of electrolytes on blood pressure: a brief summary of meta-analyses. Nutrients. 2019;11(6):1362.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.
Pandey A, LaMonte M, Klein L, Ayers C, Psaty BM, Eaton CB, et al. Relationship between physical activity, body mass index, and risk of heart failure. J Am Coll Cardiol. 2017;69(9):1129–42.
Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42(5):878–84.
Carbone S, Canada JM, Billingsley HE, Siddiqui MS, Elagizi A, Lavie CJ. Obesity paradox in cardiovascular disease: where do we stand? Vasc Health Risk Manag. 2019;15:89–100.
Kario K, Nomura A, Harada N, Okura A, Nakagawa K, Tanigawa T, et al. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial. Eur Heart J. 2021;42(40):4111–22.
Piotrowicz E, Zielinski T, Bodalski R, Rywik T, Dobraszkiewicz-Wasilewska B, Sobieszczanska-Malek M, et al. Home-based telemonitored nordic walking training is well accepted, safe, effective and has high adherence among heart failure patients, including those with cardiovascular implantable electronic devices: a randomised controlled study. Eur J Prev Cardiol. 2015;22(11):1368–77.
O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301(14):1439–50.
Aggarwal M, Bozkurt B, Panjrath G, Aggarwal B, Ostfeld RJ, Barnard ND, et al. Lifestyle modifications for preventing and treating heart failure. J Am Coll Cardiol. 2018;72(19):2391–405.
Fu J, Liu Y, Zhang L, Zhou L, Li D, Quan H, et al. Nonpharmacologic interventions for reducing blood pressure in adults with prehypertension to established hypertension. J Am Heart Assoc. 2020;9(19):e016804.
Roerecke M, Tobe SW, Kaczorowski J, Bacon SL, Vafaei A, Hasan OSM, et al. Sex-specific associations between alcohol consumption and incidence of hypertension: a systematic review and meta-analysis of cohort studies. J Am Heart Assoc. 2018;7(13):e008202.
Fernandez-Sola J. The effects of ethanol on the heart: alcoholic cardiomyopathy. Nutrients. 2020;12(2):572.
Biddinger KJ, Emdin CA, Haas ME, Wang M, Hindy G, Ellinor PT, et al. Association of habitual alcohol intake with risk of cardiovascular disease. JAMA Netw Open. 2022;5(3):e223849.
Pullen PR, Seffens WS, Thompson WR. Yoga for heart failure: a review and future research. Int J Yoga. 2018;11(2):91–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zieliński, T., Januszewicz, A. (2023). Nonpharmacological Treatment in Hypertensive Patients with Heart Failure. In: Dorobantu, M., Voicu, V., Grassi, G., Agabiti-Rosei, E., Mancia, G. (eds) Hypertension and Heart Failure. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-031-39315-0_24
Download citation
DOI: https://doi.org/10.1007/978-3-031-39315-0_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-39314-3
Online ISBN: 978-3-031-39315-0
eBook Packages: MedicineMedicine (R0)